Sfoglia per Autore
HIV pharmacoresistance
2002-01-01 Carosi, Giampiero; Torti, Carlo; QUIROS ROLDAN, Maria Eugenia
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48 week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial
2003-01-01 Mazzotta, F.; LO CAPUTO, S.; Torti, Carlo; Tinelli, C.; Pierotti, P.; Castelli, Francesco; Lazzarin, A.; Angarano, G.; Maserati, Renato; Gianotti, N.; Ladisa, N.; QUIROS ROLDAN, Maria Eugenia; Rinehart, A. R.; Carosi, Giampiero
Polymorphic immune restoration syndrome after effective HAART
2003-01-01 QUIROS ROLDAN, Maria Eugenia; Torti, Carlo; Casari, Salvatore; Moretti, F; Puoti, Massimo; Carosi, Giampiero; Bercich, L.
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital
2003-01-01 QUIROS ROLDAN, Maria Eugenia; Moretti, F; Torti, Carlo; Casari, Salvatore; Castelli, Francesco; Beltrame, A; Carosi, Giampiero
SENV infection in HIV-positive patients: prevalence, subtype characterization, and impact on HIV disease progression
2003-01-01 QUIROS ROLDAN, Maria Eugenia; Torti, Carlo; Imberti, L; Casari, Salvatore; Soriano, V; Moretti, F; Pirovano, S; Carosi, Giampiero
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations
2003-01-01 Scudeller, L.; Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Patroni, Andrea; LO CAPUTO, S.; Moretti, F.; Mazzotta, F.; Donati, E.; Vivarelli, A.; Carosi, Giampiero
Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switch
2003-01-01 Tomasoni, Lr; Patroni, A; Torti, Carlo; Paraninfo, G; Gargiulo, F; QUIROS ROLDAN, Maria Eugenia; Uccelli, Mc; Airò, P; Tinelli, C; Carosi, Giampiero; Castelli, Francesco; Brescia MASTER Study, Group
The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients
2003-01-01 Gilleece, Y; Torti, Carlo; Mandalia, S; Gazzard, Bg; Pillay, D; Pozniak, Al
SENV infection in HIV+ patients: prevalence, subtype characterization and impact on the clinical outcome
2003-01-01 QUIROS ROLDAN, Maria Eugenia; Torti, Carlo; Imberti, L; Casari, S; Moretti, F; Pirovano, S; Castelli, Francesco; Carosi, Giampiero
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting
2003-01-01 Torti, Carlo; Casari, Salvatore; Palvarini, L; QUIROS ROLDAN, Maria Eugenia; Moretti, F; Leone, L; Patroni, A; Castelli, Francesco; Ripamonti, D; Tramarin, A; Carosi, Giampiero
Persistence of HIV-1 drug resistance mutations and emergence during antiretroviral treatment interruption: considerations from a clinical case
2003-01-01 Torti, Carlo; Moretti, F; Uccelli, Mc; Tirelli, Valeria; QUIROS ROLDAN, Maria Eugenia; Gargiulo, F; Carosi, Giampiero
Predictors of long-term immunological outcome in rebounding patients on protease inhibitor based HAART after initial successful virologic suppression: implication for timing to switching
2003-01-01 Tomasoni, L.; Patroni, A.; Torti, Carlo; Paraninfo, G.; Gargiulo, F.; QUIROS ROLDAN, Maria Eugenia; Uccelli, M. C.; Air, P.; Tinelli, C.; Castelli, Francesco
Bcl-2 expression is moderately correlated with long-term variability of CD4+ T-cell increase under successful highly active antiretroviral therapy
2003-01-01 Uccelli, M. C.; Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Tinelli, C.; Patroni, A.; Castelli, Francesco; Carosi, Giampiero; Airo', P.
Comparison between rule-based HIV-1 genotype interpretation systems and phenotype driven systems: concordance analysis and correlation with clinical outcome in heavily treated patients
2003-01-01 Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Keulen, W; Scudeller, L; Lo Caputo, S; Boucher, C; Castelli, Francesco; Mazzotta, F; Pierotti, P; Been Tiktak, Am; Buccoliero, G; De Gennaro, M; Carosi, Giampiero; Tinelli, C; GenPherex Study Group of the MaSTeR, Cohort
Characterisation of viro-immunlogical responses in a closely followed cohort oh heavily pretreated patients: evidence from the GenPheRex Study
2003-01-01 Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Scudeller, L; LO CAPUTO, S; Tomasoni, L; Castelli, Francesco; Poggio, A; DELLE FOGLIE, P; Chirianni, A; Sighinolfi, L; Mazzotta, F; Carosi, Giampiero; THE GENPHEREX GROUP OF THE MASTER, Cohort
Analisi estensiva di sequenza dei geni della trascrittasi inversa e della proteasi di HIV-1 in una coorte clinica di pazienti HIV positivi NAIVE per la terapia antiretrovirale.
2003-01-01 Torti, Carlo; Bono, L.; QUIROS ROLDAN, Maria Eugenia; Tirelli, V.; Uccelli, M. C.; Giovannelli, G.; Forleo, A.; Gargiulo, F.; Perandin, Francesca; DE FRANCESCO, Maria Antonia; Manca, Nino; Carosi, Giampiero
Genotypic resistance tests in the menagement of the HIV-infectet patient at virological failure
2003-01-01 Aceti, A; Carosi, Giampiero; Torti, Carlo
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients.
2004-01-01 Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Monno, L.; Patroni, Andrea; Saracino, A. ANGARANO G.; Tinelli, C.; LO CAPUTO, S.; Tirelli, Valeria; Mazzotta, F.; Carosi, Giampiero
The novel non-A, non-E hepatitis viruses and their pathogenic effect
2004-01-01 QUIROS ROLDAN, Maria Eugenia; Torti, Carlo; Carosi, Giampiero
HIV-associated asymmetric lipodystrophy syndrome
2004-01-01 QUIROS ROLDAN, Maria Eugenia; Moretti, F; Torti, Carlo; Casari, Salvatore; Prestini, K; Carosi, Giampiero
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| HIV pharmacoresistance | 1-gen-2002 | Carosi, Giampiero; Torti, Carlo; QUIROS ROLDAN, Maria Eugenia | |
| Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48 week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial | 1-gen-2003 | Mazzotta, F.; LO CAPUTO, S.; Torti, Carlo; Tinelli, C.; Pierotti, P.; Castelli, Francesco; Lazzarin, A.; Angarano, G.; Maserati, Renato; Gianotti, N.; Ladisa, N.; QUIROS ROLDAN, Maria Eugenia; Rinehart, A. R.; Carosi, Giampiero | |
| Polymorphic immune restoration syndrome after effective HAART | 1-gen-2003 | QUIROS ROLDAN, Maria Eugenia; Torti, Carlo; Casari, Salvatore; Moretti, F; Puoti, Massimo; Carosi, Giampiero; Bercich, L. | |
| HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital | 1-gen-2003 | QUIROS ROLDAN, Maria Eugenia; Moretti, F; Torti, Carlo; Casari, Salvatore; Castelli, Francesco; Beltrame, A; Carosi, Giampiero | |
| SENV infection in HIV-positive patients: prevalence, subtype characterization, and impact on HIV disease progression | 1-gen-2003 | QUIROS ROLDAN, Maria Eugenia; Torti, Carlo; Imberti, L; Casari, Salvatore; Soriano, V; Moretti, F; Pirovano, S; Carosi, Giampiero | |
| HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations | 1-gen-2003 | Scudeller, L.; Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Patroni, Andrea; LO CAPUTO, S.; Moretti, F.; Mazzotta, F.; Donati, E.; Vivarelli, A.; Carosi, Giampiero | |
| Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switch | 1-gen-2003 | Tomasoni, Lr; Patroni, A; Torti, Carlo; Paraninfo, G; Gargiulo, F; QUIROS ROLDAN, Maria Eugenia; Uccelli, Mc; Airò, P; Tinelli, C; Carosi, Giampiero; Castelli, Francesco; Brescia MASTER Study, Group | |
| The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients | 1-gen-2003 | Gilleece, Y; Torti, Carlo; Mandalia, S; Gazzard, Bg; Pillay, D; Pozniak, Al | |
| SENV infection in HIV+ patients: prevalence, subtype characterization and impact on the clinical outcome | 1-gen-2003 | QUIROS ROLDAN, Maria Eugenia; Torti, Carlo; Imberti, L; Casari, S; Moretti, F; Pirovano, S; Castelli, Francesco; Carosi, Giampiero | |
| Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting | 1-gen-2003 | Torti, Carlo; Casari, Salvatore; Palvarini, L; QUIROS ROLDAN, Maria Eugenia; Moretti, F; Leone, L; Patroni, A; Castelli, Francesco; Ripamonti, D; Tramarin, A; Carosi, Giampiero | |
| Persistence of HIV-1 drug resistance mutations and emergence during antiretroviral treatment interruption: considerations from a clinical case | 1-gen-2003 | Torti, Carlo; Moretti, F; Uccelli, Mc; Tirelli, Valeria; QUIROS ROLDAN, Maria Eugenia; Gargiulo, F; Carosi, Giampiero | |
| Predictors of long-term immunological outcome in rebounding patients on protease inhibitor based HAART after initial successful virologic suppression: implication for timing to switching | 1-gen-2003 | Tomasoni, L.; Patroni, A.; Torti, Carlo; Paraninfo, G.; Gargiulo, F.; QUIROS ROLDAN, Maria Eugenia; Uccelli, M. C.; Air, P.; Tinelli, C.; Castelli, Francesco | |
| Bcl-2 expression is moderately correlated with long-term variability of CD4+ T-cell increase under successful highly active antiretroviral therapy | 1-gen-2003 | Uccelli, M. C.; Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Tinelli, C.; Patroni, A.; Castelli, Francesco; Carosi, Giampiero; Airo', P. | |
| Comparison between rule-based HIV-1 genotype interpretation systems and phenotype driven systems: concordance analysis and correlation with clinical outcome in heavily treated patients | 1-gen-2003 | Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Keulen, W; Scudeller, L; Lo Caputo, S; Boucher, C; Castelli, Francesco; Mazzotta, F; Pierotti, P; Been Tiktak, Am; Buccoliero, G; De Gennaro, M; Carosi, Giampiero; Tinelli, C; GenPherex Study Group of the MaSTeR, Cohort | |
| Characterisation of viro-immunlogical responses in a closely followed cohort oh heavily pretreated patients: evidence from the GenPheRex Study | 1-gen-2003 | Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Scudeller, L; LO CAPUTO, S; Tomasoni, L; Castelli, Francesco; Poggio, A; DELLE FOGLIE, P; Chirianni, A; Sighinolfi, L; Mazzotta, F; Carosi, Giampiero; THE GENPHEREX GROUP OF THE MASTER, Cohort | |
| Analisi estensiva di sequenza dei geni della trascrittasi inversa e della proteasi di HIV-1 in una coorte clinica di pazienti HIV positivi NAIVE per la terapia antiretrovirale. | 1-gen-2003 | Torti, Carlo; Bono, L.; QUIROS ROLDAN, Maria Eugenia; Tirelli, V.; Uccelli, M. C.; Giovannelli, G.; Forleo, A.; Gargiulo, F.; Perandin, Francesca; DE FRANCESCO, Maria Antonia; Manca, Nino; Carosi, Giampiero | |
| Genotypic resistance tests in the menagement of the HIV-infectet patient at virological failure | 1-gen-2003 | Aceti, A; Carosi, Giampiero; Torti, Carlo | |
| Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients. | 1-gen-2004 | Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Monno, L.; Patroni, Andrea; Saracino, A. ANGARANO G.; Tinelli, C.; LO CAPUTO, S.; Tirelli, Valeria; Mazzotta, F.; Carosi, Giampiero | |
| The novel non-A, non-E hepatitis viruses and their pathogenic effect | 1-gen-2004 | QUIROS ROLDAN, Maria Eugenia; Torti, Carlo; Carosi, Giampiero | |
| HIV-associated asymmetric lipodystrophy syndrome | 1-gen-2004 | QUIROS ROLDAN, Maria Eugenia; Moretti, F; Torti, Carlo; Casari, Salvatore; Prestini, K; Carosi, Giampiero |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile